Previous 10 | Next 10 |
Do you, or did you, own shares of Exscientia plc (NASDAQ:EXAI)? Did you purchase your shares between March 23, 2022 and February 12, 2024, inclusive? Did you lose money in your investment in Exscientia plc? Do you want to discuss your right s? NEW YORK, NY / ACCESSWIRE / May ...
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 25, 2024 in Exscientia plc Lawsuit - EXAI Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 25, 2024 in Exscientia plc Lawsuit - EXAI PR Newswire NEW YORK , ...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Exscientia To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - May 5, 2024) - Faruqi & Faruqi, LLP, a leading national s...
NEW YORK, May 03, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Exscientia plc ("Exscientia" or the "Company") (NASDAQ: EXAI) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Exscientia investors who ...
2024-05-02 13:05:00 ET Summary The AI ecosystem comprises semiconductors, software, other hardware and innovative use cases, all of which play crucial roles in the advancement and adoption of AI. Realistic expectations for 2024 include the potential for a hardware refresh cycle dr...
Do you, or did you, own shares of Exscientia plc (NASDAQ:EXAI)? Did you purchase your shares between March 23, 2022 and February 12, 2024, inclusive? Did you lose money in your investment in Exscientia plc? Do you want to discuss your rights? NEW YORK, NY / ACCESSWIRE / May 1, ...
NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey on behalf of all persons and entities who purchased securities of Exscientia plc (“E...
Do you, or did you, own shares of Exscientia plc (NASDAQ:EXAI)? Did you purchase your shares between March 23, 2022 and February 12, 2024, inclusive? Did you lose money in your investment in Exscientia plc? Do you want to discuss your rights? NEW YORK, NY / ACCESSWIRE / April 30, 202...
2024-04-24 17:41:05 ET Gainers: Acrivon Therapeutics ( ACRV ) +19% . Impinj ( PI ) +10% . Exscientia ( EXAI ) +6% . Churchill Downs ( CHDN ) +5% . PowerFleet ( PWFL ) +5% . Losers: Meta Platforms ( META ) ...
2024-04-24 09:19:50 ET More on Moderna Moderna Investors Should Beware Patent-Dispute Fallout Moderna: Considering The Cancer Vaccine Angle Moderna Continues To Build A Pipeline S&P 500 stocks with biggest estimated EPS declines for Q1 Moderna sto...
News, Short Squeeze, Breakout and More Instantly...
2024-06-08 04:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
— AI drug design pioneer John P. Overington, Ph.D., appointed to Chief Technology Officer to maximise strategic technology integration and application — — Maria-Louise Fjällskog, M.D., Ph.D., appointed interim Chief Medical Officer, adding extensive oncology ...
Exscientia plc (Nasdaq: EXAI) today announced that members of Exscientia management will participate in the following upcoming investor conferences in June: Barclays Digital and Disruptive Technology Conference. Panel on Tuesday, June 11, 2024 at 9:45 a.m. BST in London, England G...